enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. How to Reset These 10 Hormones That Affect Weight This Year - AOL

   www.aol.com/reset-10-hormones-affect-weight...

   Hormone-related health conditions, like polycystic ovary syndrome (PCOS) and hypothyroidism, as well as life seasons like menopause, can lead to hormonal changes that make losing weight more ...

3. Serotonin–norepinephrine–dopamine reuptake inhibitor

   en.wikipedia.org/wiki/Serotonin–norepinephrine...

   It prevents the reuptake of NA and DA (weakly) by blocking the corresponding transporters, leading to increased noradrenergic and dopaminergic neurotransmission. This drug does not cause sexual dysfunction or weight gain like the SSRIs but has a higher incidence of nausea.

4. Study pinpoints 3 common antidepressants tied to the most ...

   www.aol.com/study-pinpoints-3-common...

   At the 1-year and 2-year marks compared to sertraline, bupropion’s estimations for weight gain were still lower. Escitalopram was still associated with weight gain after 1 year but not after 2 ...

5. Can Antidepressants Cause Weight Loss? - AOL

   www.aol.com/antidepressants-cause-weight-loss...

   A systematic review published in the journal Obesity Reviews in 2019 found that just about all of the widely-used medications for depression resulted in long-term weight gain, with the exception ...

6. List of antidepressants - Wikipedia

   en.wikipedia.org/wiki/List_of_antidepressants

   This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification.

7. Reboxetine - Wikipedia

   en.wikipedia.org/wiki/Reboxetine

   There has been much debate as to whether reboxetine is more efficacious than placebo in the treatment of depression. According to a 2009 meta-analysis of 12 second-generation antidepressants, reboxetine was no more effective than placebo, and was "significantly less" effective and less acceptable than the other drugs in treating the acute-phase of adults with unipolar major depression.